United Health Group Limited - Limited company accounts 18.2

United Health Group Limited - Limited company accounts 18.2


IRIS Accounts Production v18.2.1.62 05766627 Board of Directors 31.1.18 1.2.17 31.1.18 31.1.18 care homes true false true true false false true false Ordinary 0 0 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure057666272017-01-31057666272018-01-31057666272017-02-012018-01-31057666272016-01-31057666272016-02-012017-01-31057666272017-01-3105766627ns15:EnglandWales2017-02-012018-01-3105766627ns14:PoundSterling2017-02-012018-01-3105766627ns10:Director12017-02-012018-01-3105766627ns10:Consolidated2018-01-3105766627ns10:ConsolidatedGroupCompanyAccounts2017-02-012018-01-3105766627ns10:PrivateLimitedCompanyLtd2017-02-012018-01-3105766627ns10:Consolidatedns10:FRS1022017-02-012018-01-3105766627ns10:Consolidatedns10:Audited2017-02-012018-01-3105766627ns10:SmallCompaniesRegimeForDirectorsReport2017-02-012018-01-3105766627ns10:SmallCompaniesRegimeForAccounts2017-02-012018-01-3105766627ns10:Consolidatedns10:LargeMedium-sizedCompaniesRegimeForDirectorsReport2017-02-012018-01-3105766627ns10:Consolidatedns10:LargeMedium-sizedCompaniesRegimeForAccounts2017-02-012018-01-3105766627ns10:FullAccounts2017-02-012018-01-3105766627ns10:OrdinaryShareClass12017-02-012018-01-3105766627ns10:OrdinaryShareClass112017-02-012018-01-3105766627ns10:Consolidated2017-02-012018-01-3105766627ns10:Director22017-02-012018-01-3105766627ns10:Director32017-02-012018-01-3105766627ns10:Director42017-02-012018-01-3105766627ns10:CompanySecretary12017-02-012018-01-3105766627ns10:RegisteredOffice2017-02-012018-01-3105766627ns10:Consolidated2016-02-012017-01-3105766627ns5:CurrentFinancialInstruments2018-01-3105766627ns5:CurrentFinancialInstruments2017-01-3105766627ns5:ShareCapital2018-01-3105766627ns5:ShareCapital2017-01-3105766627ns5:RetainedEarningsAccumulatedLosses2018-01-3105766627ns5:RetainedEarningsAccumulatedLosses2017-01-3105766627ns5:ShareCapital2016-01-3105766627ns5:RetainedEarningsAccumulatedLosses2016-01-3105766627ns5:RetainedEarningsAccumulatedLosses2016-02-012017-01-3105766627ns5:ShareCapital2017-02-012018-01-3105766627ns5:RetainedEarningsAccumulatedLosses2017-02-012018-01-3105766627ns5:NetGoodwill2017-02-012018-01-3105766627ns5:LandBuildingsns5:ShortLeaseholdAssets2017-02-012018-01-3105766627ns5:PlantMachinery2017-02-012018-01-3105766627ns5:FurnitureFittings2017-02-012018-01-3105766627ns5:MotorVehicles2017-02-012018-01-310576662712017-02-012018-01-3105766627ns5:ReportableOperatingSegment12017-02-012018-01-3105766627ns5:ReportableOperatingSegment12016-02-012017-01-3105766627ns5:ReportableOperatingSegment22017-02-012018-01-3105766627ns5:ReportableOperatingSegment22016-02-012017-01-3105766627ns5:TotalReportableOperatingSegmentsIncludingAnyUnallocatedAmount2017-02-012018-01-3105766627ns5:TotalReportableOperatingSegmentsIncludingAnyUnallocatedAmount2016-02-012017-01-3105766627ns5:PlantEquipmentOtherAssetsUnderOperatingLeases2017-02-012018-01-3105766627ns5:PlantEquipmentOtherAssetsUnderOperatingLeases2016-02-012017-01-3105766627ns5:OwnedAssets2017-02-012018-01-3105766627ns5:OwnedAssets2016-02-012017-01-3105766627ns5:NetGoodwill2016-02-012017-01-310576662712017-02-012018-01-310576662712016-02-012017-01-3105766627ns5:NetGoodwill2017-01-3105766627ns5:NetGoodwill2018-01-3105766627ns5:NetGoodwill2017-01-3105766627ns5:LandBuildings2017-01-3105766627ns5:LandBuildingsns5:ShortLeaseholdAssets2017-01-3105766627ns5:MotorVehicles2017-01-3105766627ns5:LandBuildings2017-02-012018-01-3105766627ns5:LandBuildings2018-01-3105766627ns5:LandBuildingsns5:ShortLeaseholdAssets2018-01-3105766627ns5:MotorVehicles2018-01-3105766627ns5:LandBuildings2017-01-3105766627ns5:LandBuildingsns5:ShortLeaseholdAssets2017-01-3105766627ns5:MotorVehicles2017-01-3105766627ns5:CostValuation2017-01-3105766627ns5:CurrentFinancialInstrumentsns5:WithinOneYear2018-01-3105766627ns5:CurrentFinancialInstrumentsns5:WithinOneYear2017-01-3105766627ns5:WithinOneYear2018-01-3105766627ns5:WithinOneYear2017-01-3105766627ns5:BetweenOneFiveYears2018-01-3105766627ns5:BetweenOneFiveYears2017-01-3105766627ns5:AllPeriods2018-01-3105766627ns5:AllPeriods2017-01-3105766627ns5:AcceleratedTaxDepreciationDeferredTax2018-01-3105766627ns5:AcceleratedTaxDepreciationDeferredTax2017-01-3105766627ns5:TaxLossesCarry-forwardsDeferredTax2018-01-3105766627ns5:TaxLossesCarry-forwardsDeferredTax2017-01-3105766627ns5:DeferredTaxation2017-01-3105766627ns5:DeferredTaxation2017-02-012018-01-3105766627ns5:DeferredTaxation2018-01-3105766627ns10:OrdinaryShareClass12018-01-31


REGISTERED NUMBER: 05766627 (England and Wales)
















UNITED HEALTH GROUP LIMITED

GROUP STRATEGIC REPORT,

REPORT OF THE DIRECTORS AND

AUDITED

CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JANUARY 2018






UNITED HEALTH GROUP LIMITED (REGISTERED NUMBER: 05766627)






CONTENTS OF THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2018




Page

Company Information 1

Group Strategic Report 2

Report of the Directors 4

Report of the Independent Auditors 6

Consolidated Income Statement 8

Consolidated Other Comprehensive Income 9

Consolidated Statement of Financial Position 10

Company Statement of Financial Position 11

Consolidated Statement of Changes in Equity 12

Company Statement of Changes in Equity 13

Consolidated Statement of Cash Flows 14

Notes to the Consolidated Statement of Cash Flows 15

Notes to the Consolidated Financial Statements 16


UNITED HEALTH GROUP LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 JANUARY 2018







DIRECTORS: Ms M T Cheriton-Metcalfe
C R Jackson
P J Pearson
I R Pullan



SECRETARY: M I Brown



REGISTERED OFFICE: The Old Coach House
Gainsborough Road
Drinsey Nook
Lincoln
Lincolnshire
LN1 2JJ



REGISTERED NUMBER: 05766627 (England and Wales)



SENIOR STATUTORY AUDITOR: Timothy Godson FCA



AUDITORS: Duncan & Toplis Limited, Statutory Auditor
4 Henley Way
Doddington Road
Lincoln
Lincolnshire
LN6 3QR

UNITED HEALTH GROUP LIMITED (REGISTERED NUMBER: 05766627)

GROUP STRATEGIC REPORT
FOR THE YEAR ENDED 31 JANUARY 2018

The directors present their strategic report of the company and the group for the year ended 31 January 2018.

REVIEW OF BUSINESS
We aim to present a balanced and comprehensive review of the development and performance of our group business
during the year and its position at the year end. Our review is consistent with the size and non-complex nature of our
business and is written in the context of the risks and uncertainties that we face.

We still consider the key performance indicators of the group to be those that communicate the financial
performance and strength of the company as a whole, these being turnover, profits before tax and net assets.

We are pleased to report a consistent level of turnover in the year at £12,139,946 compared to £12,226,802 in 2017.
This has been achieved in both the main trading companies, United Health Limited and Barford Children's Services
Limited.

Overall, the group has made an increased profit before tax of £1,887,920 compared to a profit of £1,648,208 in 2017.

The current economic conditions continue to provide an element of uncertainty over the level of funding available for
the types of services provided by the majority of the group.

Further details on individual company performance can be found in the strategic reports of the individual company
accounts.

In our opinion, the group will have sufficient resources available to manage its business risks and we expect that the
present level of activity will be sustained for the foreseeable future.

Position at the financial reporting date

The directors consider the group to be in a solid financial position at the financial position date, with accumulated
distributable reserves of approximately £2,800,000.

Management remains mindful of the competitive environment in which the group operates and the need to maintain
close control over the group's working capital and financial position.

Borrowings and Risk Management

The group's principal financial instruments comprise bank balances, bank loans, trade creditors and trade debtors. The
main purpose of these instruments is to raise funds for the group operations and capital investment. The group's
approach to managing other risks applicable to the financial instruments minimised the risk to a level that the
Directors consider acceptable.

Trade debtors are managed in respect of credit and cash flow risk by policies concerning the credit offered to
customers and the regular monitoring of amounts outstanding for both time and credit limits.

Trade creditors liquidity risk is managed by ensuring sufficient funds are available to meet amounts due.


UNITED HEALTH GROUP LIMITED (REGISTERED NUMBER: 05766627)

GROUP STRATEGIC REPORT
FOR THE YEAR ENDED 31 JANUARY 2018

PRINCIPAL RISKS AND UNCERTAINTIES
The group is affected by a number of factors, the principal ones of which are:

- The group is exposed to the risk of negative developments in financial markets and the sectors in which it operates,
either directly or through the impact on the group's bankers, suppliers or customers. These developments can result
in recession, inflation, deflation, restrictions in the availability of credit, impact on demand from customers, problems
in the supplier base, increases in financing costs or in the cost of utilities. Such developments might increase operating
costs, reduce revenues, lower asset values or result in the businesses being unable to meet in full its strategic
objectives.

- The group operates in a competitive market, and failure to compete effectively in terms of price and quality can have
an adverse effect on demand and / or margins.

The group mitigates risk in several ways:

- The group has in place an organisational structure with clearly defined lines of responsibility and delegation of
authority. There are established policies and procedures for the setting of corporate strategies; financial planning and
budgeting; for information and reporting systems; for systems of operational and financial internal control; for
assessment of risk; and for monitoring operations and performance.

- Management and staff at all levels work closely with customers and suppliers to operate as effectively and efficiently
as possible, whilst maintaining long term working relationships, innovation and good lines of communication.

- The group operates a recruitment and selection process to ensure employees are experienced and competent in
their work. The workforce is trained to be alert, responsive to customer needs, and to operate in line with the group's
corporate objectives.

FUTURE DEVELOPMENT
The group's strategy is to continue organic growth using the existing business model.

ON BEHALF OF THE BOARD:





P J Pearson - Director


28 September 2018

UNITED HEALTH GROUP LIMITED (REGISTERED NUMBER: 05766627)

REPORT OF THE DIRECTORS
FOR THE YEAR ENDED 31 JANUARY 2018

The directors present their report with the financial statements of the company and the group for the year ended
31 January 2018.

DIVIDENDS
No dividends will be distributed for the year ended 31 January 2018.

DIRECTORS
The directors shown below have held office during the whole of the period from 1 February 2017 to the date of this
report.

Ms M T Cheriton-Metcalfe
C R Jackson
P J Pearson
I R Pullan

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Group Strategic Report, the Report of the Directors and the financial
statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the
directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted
Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors
must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of
affairs of the company and the group and of the profit or loss of the group for that period. In preparing these
financial statements, the directors are required to:

- select suitable accounting policies and then apply them consistently;
- make judgements and accounting estimates that are reasonable and prudent;
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company
will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the
company's and the group's transactions and disclose with reasonable accuracy at any time the financial position of the
company and the group and enable them to ensure that the financial statements comply with the Companies Act
2006. They are also responsible for safeguarding the assets of the company and the group and hence for taking
reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies
Act 2006) of which the group's auditors are unaware, and each director has taken all the steps that he or she ought to
have taken as a director in order to make himself or herself aware of any relevant audit information and to establish
that the group's auditors are aware of that information.

UNITED HEALTH GROUP LIMITED (REGISTERED NUMBER: 05766627)

REPORT OF THE DIRECTORS
FOR THE YEAR ENDED 31 JANUARY 2018


AUDITORS
The auditors, Duncan & Toplis Limited, Statutory Auditor, will be proposed for re-appointment at the forthcoming
Annual General Meeting.

ON BEHALF OF THE BOARD:





P J Pearson - Director


28 September 2018

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
UNITED HEALTH GROUP LIMITED

Opinion
We have audited the financial statements of United Health Group Limited (the 'parent company') and its subsidiaries
(the 'group') for the year ended 31 January 2018 which comprise the Consolidated Income Statement, Consolidated
Other Comprehensive Income, Consolidated Statement of Financial Position, Company Statement of Financial
Position, Consolidated Statement of Changes in Equity, Company Statement of Changes in Equity, Consolidated
Statement of Cash Flows and Notes to the Consolidated Statement of Cash Flows, Notes to the Financial Statements,
including a summary of significant accounting policies. The financial reporting framework that has been applied in
their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard
102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally
Accepted Accounting Practice).

In our opinion the financial statements:
-give a true and fair view of the state of the group's and of the parent company affairs as at 31 January 2018 and of
the group's profit for the year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law.
Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the
financial statements section of our report. We are independent of the group in accordance with the ethical
requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard,
and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the
audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
We have nothing to report in respect of the following matters in relation to which the ISAs (UK) require us to report to
you where:
- the directors' use of the going concern basis of accounting in the preparation of the financial statements is not
appropriate; or
- the directors have not disclosed in the financial statements any identified material uncertainties that may cast
significant doubt about the group's ability to continue to adopt the going concern basis of accounting for a period
of at least twelve months from the date when the financial statements are authorised for issue.

Other information
The directors are responsible for the other information. The other information comprises the information in the
Group Strategic Report and the Report of the Directors, but does not include the financial statements and our Report
of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and we do not express any form of
assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in
doing so, consider whether the other information is materially inconsistent with the financial statements or our
knowledge obtained in the audit or otherwise appears to be materially misstated. If, based on the work we have
performed, we conclude that there is a material misstatement of this other information, we are required to report
that fact. We have nothing to report in this regard.

Opinion on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Group Strategic Report and the Report of the Directors for the financial year for which
the financial statements are prepared is consistent with the financial statements; and
- the Group Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal
requirements.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
UNITED HEALTH GROUP LIMITED


Matters on which we are required to report by exception
In the light of the knowledge and understanding of the group and the parent company and its environment obtained
in the course of the audit, we have not identified material misstatements in the Group Strategic Report or the Report
of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to
you if, in our opinion:
- adequate accounting records have not been kept by the parent company, or returns adequate for our audit have
not been received from branches not visited by us; or
- the parent company financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of directors' remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.

Responsibilities of directors
As explained more fully in the Statement of Directors' Responsibilities set out on page four, the directors are
responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view,
and for such internal control as the directors determine necessary to enable the preparation of financial statements
that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the group's and the parent
company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using
the going concern basis of accounting unless the directors either intend to liquidate the group or the parent company
or to cease operations, or have no realistic alternative but to do so.

Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from
material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion.
Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with
ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and
are considered material if, individually or in the aggregate, they could reasonably be expected to influence the
economic decisions of users taken on the basis of these financial statements.

A further description of our responsibilities for the audit of the financial statements is located on the Financial
Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of
the Auditors.

Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the
Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those
matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent
permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's
members as a body, for our audit work, for this report, or for the opinions we have formed.




Timothy Godson FCA (Senior Statutory Auditor)
for and on behalf of Duncan & Toplis Limited, Statutory Auditor
4 Henley Way
Doddington Road
Lincoln
Lincolnshire
LN6 3QR

8 October 2018

UNITED HEALTH GROUP LIMITED (REGISTERED NUMBER: 05766627)

CONSOLIDATED INCOME STATEMENT
FOR THE YEAR ENDED 31 JANUARY 2018

2018 2017
Notes £    £   

TURNOVER 3 12,139,946 12,226,802

Cost of sales 8,078,194 8,232,640
GROSS PROFIT 4,061,752 3,994,162

Administrative expenses 2,005,437 2,200,709
2,056,315 1,793,453

Other operating income 172,162 241,524
OPERATING PROFIT 5 2,228,477 2,034,977


Interest payable and similar expenses 6 340,557 386,769
PROFIT BEFORE TAXATION 1,887,920 1,648,208

Tax on profit 7 338,531 339,591
PROFIT FOR THE FINANCIAL YEAR 1,549,389 1,308,617
Profit attributable to:
Owners of the parent 1,549,389 1,308,664
Non-controlling interests - (47 )
1,549,389 1,308,617

UNITED HEALTH GROUP LIMITED (REGISTERED NUMBER: 05766627)

CONSOLIDATED OTHER COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 JANUARY 2018

2018 2017
Notes £    £   

PROFIT FOR THE YEAR 1,549,389 1,308,617


OTHER COMPREHENSIVE INCOME
Tax relating other comprehensive income 80,621 45,968
Income tax relating to other comprehensive
income

-

-
OTHER COMPREHENSIVE INCOME FOR THE
YEAR, NET OF INCOME TAX

80,621

45,968
TOTAL COMPREHENSIVE INCOME FOR THE
YEAR

1,630,010

1,354,585

Total comprehensive income attributable to:
Owners of the parent 1,630,010 1,354,632
Non-controlling interests - (47 )
1,630,010 1,354,585

UNITED HEALTH GROUP LIMITED (REGISTERED NUMBER: 05766627)

CONSOLIDATED STATEMENT OF FINANCIAL POSITION
31 JANUARY 2018

2018 2017
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 9 (2,060,546 ) (2,113,380 )
Tangible assets 10 30,703,162 29,941,036
Investments 11 - -
28,642,616 27,827,656

CURRENT ASSETS
Stocks 12 1,948,187 2,264,120
Debtors 13 916,606 955,104
Cash at bank and in hand 412,776 647,519
3,277,569 3,866,743
CREDITORS
Amounts falling due within one year 14 6,119,331 8,621,059
NET CURRENT LIABILITIES (2,841,762 ) (4,754,316 )
TOTAL ASSETS LESS CURRENT LIABILITIES 25,800,854 23,073,340

CREDITORS
Amounts falling due after more than one
year

15

(14,859,959

)

(13,673,329

)

PROVISIONS FOR LIABILITIES 20 (1,753,275 ) (1,842,405 )
NET ASSETS 9,187,620 7,557,606

CAPITAL AND RESERVES
Called up share capital 21 904 900
Revaluation reserve 22 6,387,543 6,306,922
Retained earnings 22 2,812,358 1,262,969
SHAREHOLDERS' FUNDS 9,200,805 7,570,791

NON-CONTROLLING INTERESTS (13,185 ) (13,185 )
TOTAL EQUITY 9,187,620 7,557,606

The financial statements were approved by the Board of Directors on 28 September 2018 and were signed on its
behalf by:





P J Pearson - Director


UNITED HEALTH GROUP LIMITED (REGISTERED NUMBER: 05766627)

COMPANY STATEMENT OF FINANCIAL POSITION
31 JANUARY 2018

2018 2017
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 9 - -
Tangible assets 10 1,893,033 1,906,073
Investments 11 9,203,483 9,203,483
11,096,516 11,109,556

CURRENT ASSETS
Stocks 12 - 125,000
Debtors 13 76,594 166,234
Cash at bank 9,660 105,187
86,254 396,421
CREDITORS
Amounts falling due within one year 14 9,486,563 9,677,056
NET CURRENT LIABILITIES (9,400,309 ) (9,280,635 )
TOTAL ASSETS LESS CURRENT LIABILITIES 1,696,207 1,828,921

PROVISIONS FOR LIABILITIES 20 42 1,333
NET ASSETS 1,696,165 1,827,588

CAPITAL AND RESERVES
Called up share capital 21 904 900
Retained earnings 1,695,261 1,826,688
SHAREHOLDERS' FUNDS 1,696,165 1,827,588

Company's (loss)/profit for the financial
year

(131,427

)

108,878

The financial statements have been prepared in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

The financial statements were approved by the Board of Directors on 28 September 2018 and were signed on its
behalf by:





P J Pearson - Director


UNITED HEALTH GROUP LIMITED (REGISTERED NUMBER: 05766627)

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 JANUARY 2018

Called up
share Retained Revaluation
capital earnings reserve
£    £    £   

Balance at 1 February 2016 900 (45,695 ) 6,260,954

Changes in equity
Total comprehensive income - 1,308,664 45,968
Balance at 31 January 2017 900 1,262,969 6,306,922

Changes in equity
Issue of share capital 4 - -
Total comprehensive income - 1,549,389 80,621
Balance at 31 January 2018 904 2,812,358 6,387,543
Non-controlling Total
Total interests equity
£    £    £   

Balance at 1 February 2016 6,216,159 (13,138 ) 6,203,021

Changes in equity
Total comprehensive income 1,354,632 (47 ) 1,354,585
Balance at 31 January 2017 7,570,791 (13,185 ) 7,557,606

Changes in equity
Issue of share capital 4 - 4
Total comprehensive income 1,630,010 - 1,630,010
Balance at 31 January 2018 9,200,805 (13,185 ) 9,187,620

UNITED HEALTH GROUP LIMITED (REGISTERED NUMBER: 05766627)

COMPANY STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 JANUARY 2018

Called up
share Retained Total
capital earnings equity
£    £    £   

Balance at 1 February 2016 900 1,717,810 1,718,710

Changes in equity
Total comprehensive income - 108,878 108,878
Balance at 31 January 2017 900 1,826,688 1,827,588

Changes in equity
Issue of share capital 4 - 4
Total comprehensive income - (131,427 ) (131,427 )
Balance at 31 January 2018 904 1,695,261 1,696,165

UNITED HEALTH GROUP LIMITED (REGISTERED NUMBER: 05766627)

CONSOLIDATED STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 JANUARY 2018

2018 2017
Notes £    £   
Cash flows from operating activities
Cash generated from operations 1 2,541,157 2,938,318
Interest paid (340,557 ) (386,769 )
Tax paid (96,801 ) -
Taxation refund - 834
Interest paid - 122
Net cash from operating activities 2,103,799 2,552,505

Cash flows from investing activities
Purchase of tangible fixed assets (1,062,581 ) (334,229 )
Sale of tangible fixed assets 20,973 821,265
Net cash from investing activities (1,041,608 ) 487,036

Cash flows from financing activities
New loans in year 2,810,000 16,708
Loan repayments in year (1,569,285 ) (2,853,060 )
Amount introduced by directors 3,847,445 -
Amount withdrawn by directors (6,391,916 ) -
Share issue 4 -
Net cash from financing activities (1,303,752 ) (2,836,352 )

(Decrease)/increase in cash and cash equivalents (241,561 ) 203,189
Cash and cash equivalents at beginning of
year

2

643,826

440,637

Cash and cash equivalents at end of year 2 402,265 643,826

UNITED HEALTH GROUP LIMITED (REGISTERED NUMBER: 05766627)

NOTES TO THE CONSOLIDATED STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 JANUARY 2018

1. RECONCILIATION OF PROFIT BEFORE TAXATION TO CASH GENERATED FROM OPERATIONS
2018 2017
£    £   
Profit before taxation 1,887,920 1,648,208
Depreciation charges 226,605 207,240
Loss on disposal of fixed assets 43 195,312
Finance costs 340,557 386,769
2,455,125 2,437,529
Decrease in stocks 315,933 538,709
Decrease/(increase) in trade and other debtors 7,033 (16,151 )
Decrease in trade and other creditors (236,934 ) (21,769 )
Cash generated from operations 2,541,157 2,938,318

2. CASH AND CASH EQUIVALENTS

The amounts disclosed on the Statement of Cash Flows in respect of cash and cash equivalents are in respect
of these Statement of Financial Position amounts:

Year ended 31 January 2018
31.1.18 1.2.17
£    £   
Cash and cash equivalents 412,776 647,519
Bank overdrafts (10,511 ) (3,693 )
402,265 643,826
Year ended 31 January 2017
31.1.17 1.2.16
£    £   
Cash and cash equivalents 647,519 444,447
Bank overdrafts (3,693 ) (3,810 )
643,826 440,637

UNITED HEALTH GROUP LIMITED (REGISTERED NUMBER: 05766627)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2018

1. STATUTORY INFORMATION

United Health Group Limited is a private company, limited by shares , registered in England and Wales. The
company's registered number and registered office address can be found on the General Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The
Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The
financial statements have been prepared under the historical cost convention as modified by the revaluation
of certain assets.

Basis of consolidation
The group financial statements consolidate the financial statements of United Health Group Limited and the
entities it controls (its subsidiaries) drawn up to 31 January each year. Control comprises the power to govern
the financial and operating policies of the investee via control of the issued share capital of those companies.

Subsidiaries are consolidated from the date of their acquisition, being the date on which the group obtains
control, and continue to be consolidated until the date that such control ceases.

The financial statements of subsidiaries are prepared for the same reporting year as the parent company, using
consistent accounting policies.

Subsidiaries acquired during the year are consolidated under the acquisition method of accounting, whereby
underlying assets and liabilities, and the consideration paid, are recorded at their fair values. The deficit of the
fair value of consideration paid less than the fair value of net assets acquired is presented as negative
consolidation goodwill.

Intercompany balances and transactions, including unrealised profits arising from intragroup transactions,
have been eliminated.

Related party exemption
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The
Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party
transactions with wholly owned subsidiaries within the group.

Transactions between group entities which have been eliminated on consolidation are not disclosed within the
financial statements.

UNITED HEALTH GROUP LIMITED (REGISTERED NUMBER: 05766627)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2018

2. ACCOUNTING POLICIES - continued

Significant judgements and estimates
In the application of the Group's accounting policies, management is required to make judgements, estimates
and assumptions about the carrying value of assets and liabilities that are not readily apparent from other
sources. The estimates and underlying assumptions are based on historical experience and other factors that
are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting
estimates are recognised in the period in which the estimate is revised if the revision affects only that period,
or in the period of the revision and future periods if the revision affects both current and future periods.

The key sources of estimation uncertainty that have a significant effect on the amounts recognised in the
financial statements are described below:

(i) Useful economic lives of tangible assets

The annual depreciation charge for tangible assets is sensitive to changes in the estimated useful economic
lives and residual values of the assets. The useful economic lives and residual values are re-assessed annually.
They are amended when necessary to reflect current estimates, based on technological advancement, future
investments, economic utilisation and the physical condition of the assets. See note 10 for the carrying amount
of property, plant and equipment, and accounting policy note for the useful economic lives for each class of
assets.

Turnover
Turnover represents amounts charged to customers for goods and services provided during the year, excluding
value added tax. Revenue is recognised in the period in which services are performed.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2007, is being amortised evenly over its estimated useful life of fifty years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Short leasehold - Straight line over remainder of lease
Plant and machinery - 25% on cost
Fixtures and fittings - 25% on cost and 20% on cost
Motor vehicles - 25% on cost

Stocks
Stocks are valued at the lower of cost and estimated selling price less costs to sell, after making due allowance
for obsolete and slow moving items.

UNITED HEALTH GROUP LIMITED (REGISTERED NUMBER: 05766627)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2018

2. ACCOUNTING POLICIES - continued

Financial instruments
The group has chosen to adopt the Sections 11 and 12 of FRS 102 in respect of financial instruments.

Basic financial assets, including trade and other debtors and cash and bank balances are initially recognised at
transaction price, unless the arrangement constitute a financing transaction, where the transaction is
measured at the present value of the future receipts discounted at a market rate of interest.

At the end of each reporting period, financial assets measured at amortised cost are assessed for objective
evidence of impairment. If an asset is impaired, the impairment loss is the difference between the carrying
amount and the present value of the estimated cash flows discounted at the asset's original effective interest
rate. The impairment loss is recognised in the income statement.

Basic financial liabilities, including trade and other creditors, bank loans, loans from fellow group companies
and preference shares that are classified as debt, are initially recognised at transaction price, unless the
arrangement constitutes a financing transaction, where the debt instrument is measured at the present value
of the future receipts discounted at a market rate of interest.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of
business from suppliers. Accounts payable are classified as current liabilities if payment is due within one year
or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at
transaction price and subsequently measured at amortised cost using the effective interest method.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Consolidated Income
Statement, except to the extent that it relates to items recognised in other comprehensive income or directly
in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or
substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the
statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different
from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and
laws that have been enacted or substantively enacted by the year end and that are expected to apply to the
reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that
they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

UNITED HEALTH GROUP LIMITED (REGISTERED NUMBER: 05766627)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2018

2. ACCOUNTING POLICIES - continued

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the statement of financial
position date. Those held under hire purchase contracts are depreciated over their estimated useful lives.
Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever
is the shorter.

The interest element of these obligations is charged to the income statement over the relevant period. The
capital element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to income statement on a straight line basis over the period of
the lease.

Pension costs and other post-retirement benefits
The group operates a defined contribution pension scheme. Contributions payable to the group's pension
scheme are charged to income statement in the period to which they relate.

Loans and borrowings
Loans and borrowings are initially recognised at the transaction price including transaction costs.
Subsequently, they are measured at amortised cost using the effective interest rate method, less impairment.
If an arrangement constitutes a finance transaction it is measured at present value.

3. TURNOVER

The turnover and profit before taxation are attributable to the one principal activity of the group.

An analysis of turnover by class of business is given below:

2018 2017
£    £   
Sale of goods 443,356 740,620
Rendering of services 11,696,590 11,486,182
12,139,946 12,226,802

4. EMPLOYEES AND DIRECTORS
2018 2017
£    £   
Wages and salaries 6,437,410 6,425,525
Social security costs 407,950 407,567
Other pension costs 55,127 64,581
6,900,487 6,897,673

The average number of employees during the year was as follows:
2018 2017

Administrative staff 7 12
Management staff 3 3
Nursing 426 459
436 474

UNITED HEALTH GROUP LIMITED (REGISTERED NUMBER: 05766627)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2018

4. EMPLOYEES AND DIRECTORS - continued

The average number of employees by undertakings that were proportionately consolidated during the year
was 436 (2017 - 474 ) .

2018 2017
£    £   
Directors' remuneration 197,833 224,848
Directors' pension contributions to money purchase schemes 10,171 10,479

The number of directors to whom retirement benefits were accruing was as follows:

Money purchase schemes 2 2

5. OPERATING PROFIT

The operating profit is stated after charging/(crediting):

2018 2017
£    £   
Hire of plant and machinery 16,829 4,162
Other operating leases 126,698 128,238
Depreciation - owned assets 279,439 260,074
Loss on disposal of fixed assets 43 195,312
Goodwill amortisation (52,834 ) (52,834 )
Auditors' remuneration 18,500 15,500

6. INTEREST PAYABLE AND SIMILAR EXPENSES
2018 2017
£    £   
Bank loan interest 340,557 386,769

7. TAXATION

Analysis of the tax charge
The tax charge on the profit for the year was as follows:
2018 2017
£    £   
Current tax:
UK corporation tax 319,463 100,689
Adjustment re previous years (3,888 ) -
Total current tax 315,575 100,689

Deferred tax 22,956 238,902
Tax on profit 338,531 339,591

UNITED HEALTH GROUP LIMITED (REGISTERED NUMBER: 05766627)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2018

7. TAXATION - continued

Reconciliation of total tax charge included in profit and loss
The tax assessed for the year is lower than the standard rate of corporation tax in the UK. The difference is
explained below:

2018 2017
£    £   
Profit before tax 1,887,920 1,648,208
Profit multiplied by the standard rate of corporation tax in the UK of 19%
(2017 - 20%)

358,705

329,642

Effects of:
Expenses not deductible for tax purposes (9,446 ) (8,681 )
Capital allowances in excess of depreciation (32,491 ) (6,777 )
Utilisation of tax losses - (217,413 )
Adjustments to tax charge in respect of previous periods (3,888 ) -
Difference between rates of tax 2,695 -
Losses carried forward - 32
Deferred tax 22,956 238,902
Underprovided - 3,886
Total tax charge 338,531 339,591

Tax effects relating to effects of other comprehensive income

2018
Gross Tax Net
£    £    £   
Tax relating other comprehensive income 80,621 - 80,621

2017
Gross Tax Net
£    £    £   
Tax relating other comprehensive income 45,968 - 45,968

8. INDIVIDUAL INCOME STATEMENT

As permitted by Section 408 of the Companies Act 2006, the Income Statement of the parent company is not
presented as part of these financial statements.


UNITED HEALTH GROUP LIMITED (REGISTERED NUMBER: 05766627)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2018

9. INTANGIBLE FIXED ASSETS

Group
Goodwill
£   
COST
At 1 February 2017
and 31 January 2018 (2,641,720 )
AMORTISATION
At 1 February 2017 (528,340 )
Amortisation for year (52,834 )
At 31 January 2018 (581,174 )
NET BOOK VALUE
At 31 January 2018 (2,060,546 )
At 31 January 2017 (2,113,380 )

The company has no intangible assets.

10. TANGIBLE FIXED ASSETS

Group
Freehold Short Plant and
property leasehold machinery
£    £    £   
COST
At 1 February 2017 29,362,551 99,030 20,500
Additions 840,291 - 331
At 31 January 2018 30,202,842 99,030 20,831
DEPRECIATION
At 1 February 2017 - 50,307 9,375
Charge for year - 20,161 5,208
Eliminated on disposal - - -
At 31 January 2018 - 70,468 14,583
NET BOOK VALUE
At 31 January 2018 30,202,842 28,562 6,248
At 31 January 2017 29,362,551 48,723 11,125

UNITED HEALTH GROUP LIMITED (REGISTERED NUMBER: 05766627)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2018

10. TANGIBLE FIXED ASSETS - continued

Group

Fixtures
and Motor
fittings vehicles Totals
£    £    £   
COST
At 1 February 2017 1,422,818 305,881 31,210,780
Additions 191,591 30,368 1,062,581
Disposals (7,973 ) (18,453 ) (26,426 )
At 31 January 2018 1,606,436 317,796 32,246,935
DEPRECIATION
At 1 February 2017 1,022,496 187,566 1,269,744
Charge for year 199,772 54,298 279,439
Eliminated on disposal - (5,410 ) (5,410 )
At 31 January 2018 1,222,268 236,454 1,543,773
NET BOOK VALUE
At 31 January 2018 384,168 81,342 30,703,162
At 31 January 2017 400,322 118,315 29,941,036

Included within the above is investment property as follows:

£   

At 1 February 2017 3,898,432
Additions -
Disposals -
At 31 January 2018 3,898,432

The valuation of freehold investment property as at 31 January 2018 has not been undertaken by an
independent valuer.

Freehold investment property was valued on 20 August 2014 by Bruton Knowles, an independent valuer with a
recognised and relevant professional qualification and with recent experience in the location and category of
the investment property being valued. The valuation was performed on the basis of open market value in
accordance with the Appraisal and Valuation Manual of the Royal Institute of Chartered Surveyors.

The directors do not believe that the value is materially different at the year end.

The original cost of freehold investment property is £3,053,775 for the group.

UNITED HEALTH GROUP LIMITED (REGISTERED NUMBER: 05766627)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2018

10. TANGIBLE FIXED ASSETS - continued

Company
Freehold Short Motor
property leasehold vehicles Totals
£    £    £    £   
COST
At 1 February 2017 1,842,729 99,030 19,495 1,961,254
Additions - - 19,628 19,628
Disposals - - (7,633 ) (7,633 )
At 31 January 2018 1,842,729 99,030 31,490 1,973,249
DEPRECIATION
At 1 February 2017 - 50,307 4,874 55,181
Charge for year - 20,161 4,874 25,035
At 31 January 2018 - 70,468 9,748 80,216
NET BOOK VALUE
At 31 January 2018 1,842,729 28,562 21,742 1,893,033
At 31 January 2017 1,842,729 48,723 14,621 1,906,073

Included within the above is investment property as follows:

£   

At 1 February 20171,842,729
Additions-
Disposals -
At 31 January 2018 1,842,729

The valuation of freehold investment property as at 31 January 2018 has not been undertaken by an
independent valuer.

Freehold investment property was valued on 20 August 2014 by Bruton Knowles, an independent valuer with a
recognised and relevant professional qualification and with recent experience in the location and category of
the investment property being valued. The valuation was performed on the basis of open market value in
accordance with the Appraisal and Valuation Manual of the Royal Institute of Chartered Surveyors.

The directors do not believe that the value is materially different at the year end.

The original cost of freehold investment property is £1,733,767 for the company.

UNITED HEALTH GROUP LIMITED (REGISTERED NUMBER: 05766627)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2018

11. FIXED ASSET INVESTMENTS

Company
Shares in
group
undertakings
£   
COST
At 1 February 2017
and 31 January 2018 9,203,483
NET BOOK VALUE
At 31 January 2018 9,203,483
At 31 January 2017 9,203,483



Country of
incorporation

Holding
Proportion of
shares held

Nature of business



United Health Limited

England
Ordinary
shares

100%

Operation of care homes

Through its investment in United Health Limited, the following are indirectly held subsidiary companies. The
Holding shown below is that held by United Health Limited:


Country of
incorporation

Holding
Proportion of
shares held

Nature of business
Manor Homes (Yorkshire)
Limited

England
Ordinary
shares

100%

Property development
Barford Children's Services
Limited

England
Ordinary
shares

100%

Education and social care
United Children's Services
Limited

England
Ordinary
shares

100%

Dormant

Through it's indirect investment in Barford Children Services Limited, the following are indirectly held
subsidiary companies. The holding show below is that held by Barford Children's Services Limited:


Country of
incorporation

Holding
Proportion of
shares held

Nature of business

Creative Care & Therapy Limited

England
Ordinary
shares

70%

Holding company

Barford Care Holdings Limited and Barford Park House Limited have both been dissolved during the year.

UNITED HEALTH GROUP LIMITED (REGISTERED NUMBER: 05766627)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2018

12. STOCKS

Group Company
2018 2017 2018 2017
£    £    £    £   
Stocks 1,948,187 2,139,120 - -
Work-in-progress - 125,000 - 125,000
1,948,187 2,264,120 - 125,000

Stocks recognised as an expense in the period were £315,933 (2017 - £538,709).

13. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

Group Company
2018 2017 2018 2017
£    £    £    £   
Trade debtors 608,235 555,152 18,149 9,637
Amounts owed by group undertakings - - 367 -
Other debtors 104,654 183,155 58,078 153,597
Deferred tax asset 177,535 209,000 - -
Prepayments and accrued income 26,182 7,797 - 3,000
916,606 955,104 76,594 166,234

14. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

Group Company
2018 2017 2018 2017
£    £    £    £   
Bank loans and overdrafts (see note 16) 1,192,389 1,131,486 - -
Trade creditors 86,420 126,081 - 4,570
Amounts owed to group undertakings - - 5,619,902 3,194,082
Taxation 319,463 100,689 - 25,898
Other taxes and social security 67,589 145,701 342 55,283
Other creditors 185,993 241,538 - -
Directors' current accounts 4,182,304 6,726,775 3,849,426 6,358,884
Accruals and deferred income 85,173 148,789 16,893 38,339
6,119,331 8,621,059 9,486,563 9,677,056

15. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

Group
2018 2017
£    £   
Bank loans (see note 16) 14,859,959 13,673,329

UNITED HEALTH GROUP LIMITED (REGISTERED NUMBER: 05766627)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2018

16. LOANS

An analysis of the maturity of loans is given below:

Group
2018 2017
£    £   
Amounts falling due within one year or on
demand:
Bank overdrafts 10,511 3,693
Bank loans 1,181,878 1,127,793
1,192,389 1,131,486
Amounts falling due between two and five
years:
Bank loans - 2-5 years 6,353,521 4,735,822
Amounts falling due in more than five years:
Repayable by instalments
Bank loans more 5 yr by instal 8,506,438 8,937,507

17. LEASING AGREEMENTS

Minimum lease payments fall due as follows:

Group
Non-cancellable operating
leases
2018 2017
£    £   
Within one year 125,950 125,950
Between one and five years 33,671 159,621
159,621 285,571

As lessor

The total future minimum lease payments receivable under non-cancellable operating leases are as follows:

2018 2017
£    £   

Not later than 1 year 32,130 32,130
Later than 1 year and not later than 5 years 128,520 128,520
Later than 5 years 21,420 21,420
182,070 182,070

UNITED HEALTH GROUP LIMITED (REGISTERED NUMBER: 05766627)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2018

17. LEASING AGREEMENTS - continued

Company
Non-cancellable operating
leases
2018 2017
£    £   
Within one year 18,000 18,000
Between one and five years 7,500 25,500
25,500 43,500

As lessor

The total future minimum lease payments receivable under non-cancellable operating leases are as follows:

2018 2017
£    £   

Not later than 1 year 32,130 32,130
Later than 1 year and not later than 5 years 128,520 128,520
Later than 5 years 21,420 21,420
182,070 182,070

18. SECURED DEBTS

The following secured debts are included within creditors:

Group
2018 2017
£    £   
Bank overdrafts 10,511 3,693
Bank loans 16,041,837 14,801,122
16,052,348 14,804,815

Bank borrowings are secured by legal charges over the group's freehold property and by a debenture over all
assets of the group.

UNITED HEALTH GROUP LIMITED (REGISTERED NUMBER: 05766627)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2018

19. FINANCIAL INSTRUMENTS

The group has the following financial instruments:
2018 2017
£    £   
Financial assets that are debt instruments at amortised cost
Trade debtors 608,235 555,152
Other debtors 104,654 183,155

Financial liabilities measured at amortised cost
Bank loans and overdrafts 16,052,345 14,804,815
Trade creditors 86,420 126,081
Other creditors 185,993 241,538
Directors' current accounts 4,182,304 6,726,775

The total interest income and interest expense for financial assets and financial liabilities that are not
measured at fair value through the income statement is £Nil (2017: £Nil) and £340,557 (2017: £386,769).

The company has the following financial instruments:

2018 2017
£    £   
Financial assets that are debt instruments at amortised cost
Trade debtors 18,149 9,637
Other debtors 58,078 153,597

Financial liabilities measured at amortised cost
Trade creditors - 4,570
Directors' current accounts 3,849,426 6,358,884
Amounts owed to group undertakings 5,619,902 3,194,082

The total interest income and interest expense for financial assets and financial liabilities that are not
measured at fair value through the income statement is £Nil (2017: £Nil) and £Nil (2017: £Nil).

20. PROVISIONS FOR LIABILITIES

Group Company
2018 2017 2018 2017
£    £    £    £   
Deferred tax
Accelerated capital allowances 14,526 (99,034 ) 42 1,333
Tax losses carried forward (130,469 ) - - -
Other timing differences 1,869,218 1,941,439 - -
1,753,275 1,842,405 42 1,333

Group
Deferred
tax
£   
Balance at 1 February 2017 1,842,405
Credit to Income Statement during year (89,130 )
Balance at 31 January 2018 1,753,275

UNITED HEALTH GROUP LIMITED (REGISTERED NUMBER: 05766627)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2018

20. PROVISIONS FOR LIABILITIES - continued

Company
Deferred
tax
£   
Balance at 1 February 2017 1,333
Credit to Income Statement during year (1,291 )
Balance at 31 January 2018 42

21. CALLED UP SHARE CAPITAL


Allotted, issued and fully paid:
Number: Class: Nominal 2018 2017
value: £    £   
90,400 Ordinary £0.01 904 900

400 Ordinary shares of £0.01 each were allotted and fully paid for cash at par during the year.

22. RESERVES

Group
Retained Revaluation
earnings reserve Totals
£    £    £   

At 1 February 2017 1,262,969 6,306,922 7,569,891
Profit for the year 1,549,389 1,549,389
Transfer - 80,621 80,621
At 31 January 2018 2,812,358 6,387,543 9,199,901


23. CONTINGENT LIABILITIES

The company is a party to a composite cross guarantee given to the HSBC Bank Plc between United Health
Limited, Manor Homes (Yorkshire) Limited, United Health Group Limited, Barford Children's Services Limited,
Creative Care & Therapy Limited and United Children's Services Limited (formerly United Health (Medicare)
Limited.

24. CAPITAL COMMITMENTS
2018 2017
£    £   
Contracted but not provided for in the
financial statements - 729,000

25. RELATED PARTY DISCLOSURES

UNITED HEALTH GROUP LIMITED (REGISTERED NUMBER: 05766627)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2018

25. RELATED PARTY DISCLOSURES - continued

Key management personnel of the entity or its parent (in the aggregate)
2018 2017
£    £   
Sales - 250,000
Purchases - 12,000
Rental charges - 18,000

Other related parties
2018 2017
£    £   
Loan provided - 115,914
Amount due to related party - 115,914